FDA
approval
· 2022-11-01
FDA Approved: IRBESARTAN — Supplemental Application (AvKARE)
Summary
FDA approved AvKARE's supplemental application for IRBESARTAN (irbesartan).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN (IRBESARTAN)